NCT05967052View on ClinicalTrials.gov

Investigation of Treating Chronic Fatigue Syndrome After COVID With Pharmacotherapy (Pregabalin) or Complex Rehabilitation

PHASE2RecruitingINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

October 24, 2023

Primary Completion Date

March 1, 2028

Study Completion Date

March 1, 2028

Conditions
Chronic Fatigue SyndromeCOVID-19, Long Haul
Interventions
DRUG

Pregabalin

Pregabalin pharmacotherapy

BEHAVIORAL

Independent walking training

Independent walking training

DRUG

Placebo

Placebo

BEHAVIORAL

Gradual movement therapy in the ward

Gradual movement therapy in the ward

BEHAVIORAL

Telerehabilitation

Telerehabilitation

BEHAVIORAL

Psychotherapy

Psychotherapy

Trial Locations (1)

02-637

RECRUITING

Centrum Wsparcia Badań Klinicznych, Warsaw

Sponsors
All Listed Sponsors
collaborator

Medical Research Agency, Poland

OTHER_GOV

lead

National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland

NETWORK

NCT05967052 - Investigation of Treating Chronic Fatigue Syndrome After COVID With Pharmacotherapy (Pregabalin) or Complex Rehabilitation | Biotech Hunter | Biotech Hunter